Publications by authors named "Emir Hadzijusufovic"

Claim this Profile
A
ADH5/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implications.
Jessica Atkins, Anna-Mariya Kukuyan, Monika Toma, Malgorzata Drzewiecka, Umeshkumar Vekariya, Emir Hadzijusufovic

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma.
Daniel Pölöske, Helena Sorger, Anna Schönbichler, Elvin D de Araujo, Heidi A Neubauer, Emir Hadzijusufovic

Hemasphere· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry.
Marek Niedoszytko, Aleksandra Gorska, Knut Brockow, Patrizia Bonadonna, Magdalena Lange, Emir Hadzijusufovic

Allergy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA polymerase theta-mediated DNA repair is a functional dependency and therapeutic vulnerability in DNMT3A deficient leukemia cells.
Bac Viet Le, Umeshkumar Vekariya, Monika M Toma, Margaret Nieborowska-Skorska, Marie-Christine Caron, Emir Hadzijusufovic

bioRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.
Johannes Lübke, Alicia Schmid, Deborah Christen, Hanneke N G Oude Elberink, Lambert F R Span, Emir Hadzijusufovic

Blood Adv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal medicine targeting DNA damage response eradicates leukemia.
Monika M Toma, Adam Karami, Margaret Nieborowska-Skorska, Kumaraswamy Naidu Chirtala, Monika Pepek, Emir Hadzijusufovic

Leukemia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives.
Peter Valent, Irina Sadovnik, Barbara Peter, Daniel Ivanov, Axel Schulenburg, Emir Hadzijusufovic

Expert Rev Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives.
Peter Valent, Karin Hartmann, Patrizia Bonadonna, Wolfgang R Sperr, Marek Niedoszytko, Emir Hadzijusufovic

J Allergy Clin Immunol Pract· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA polymerase θ protects leukemia cells from metabolically induced DNA damage.
Umeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska, Bac Viet Le, Marie-Christine Caron, Emir Hadzijusufovic

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Daniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, Harald Herrmann, Barbara Peter, Emir Hadzijusufovic

Am J Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engraftment in NSG mice correlates with the WHO category and prognosis in systemic mastocytosis.
Michael Willmann, Barbara Peter, Katharina Slavnitsch, Daniela Berger, Nadine Witzeneder, Emir Hadzijusufovic

Leukemia· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis.
Johannes Lübke, Juliana Schwaab, Deborah Christen, Hanneke Oude Elberink, Bart Span, Emir Hadzijusufovic

J Allergy Clin Immunol Pract· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antineoplastic efficacy profiles of avapritinib and nintedanib in D816V systemic mastocytosis: a preclinical study.
Lina Degenfeld-Schonburg, Susanne Gamperl, Gabriele Stefanzl, Anna-Katharina Schruef, Irina Sadovnik, Emir Hadzijusufovic

Am J Cancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of symptomatic Covid-19 infections in patients with mastocytosis and chronic myeloid leukemia: A comparison with the general Austrian population.
Irene Graf, Susanne Herndlhofer, Michael Kundi, Georg Greiner, Martina Sperr, Emir Hadzijusufovic

Eur J Haematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine.
Tim Heinemann, Christoph Kornauth, Yannik Severin, Gregory I Vladimer, Tea Pemovska, Emir Hadzijusufovic

Blood Cancer Discov· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis.
Roberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, Wolfgang R Sperr, Luigi Scaffidi, Emir Hadzijusufovic

Leukemia· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Synergy of Small Molecule Inhibitors Targeting -ITD Acute Myeloid Leukemia.
Javier Bregante, Anna Schönbichler, Daniel Pölöske, Lina Degenfeld-Schonburg, Garazi Monzó Contreras, Emir Hadzijusufovic

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal.
Michael Willmann, Vilma Yuzbasiyan-Gurkan, Laura Marconato, Mauro Dacasto, Emir Hadzijusufovic

Front Vet Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia.
Yüksel Filik, Karin Bauer, Emir Hadzijusufovic, Patrick Haider, Georg Greiner

Am J Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis.
Elisabeth Aberer, Wolfgang R Sperr, Agnes Bretterklieber, Alexander Avian, Emir Hadzijusufovic

J Invest Dermatol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.
Peter Valent, Cem Akin, Karin Hartmann, Gunnar Nilsson, Andreas Reiter, Emir Hadzijusufovic

Theranostics· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin.
David Fuchs, Alex Kilbertus, Karin Kofler, Nikolas von Bubnoff, Khalid Shoumariyeh, Emir Hadzijusufovic

J Allergy Clin Immunol Pract· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
Georg Greiner, Bettina Sprinzl, Aleksandra Górska, Franz Ratzinger, Michael Gurbisz, Emir Hadzijusufovic

Blood· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells.
Susanne Gamperl, Gabriele Stefanzl, Michael Willmann, Peter Valent, Emir Hadzijusufovic

Vet Med Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT5 is Expressed in CD34/CD38 Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.
Emir Hadzijusufovic, Alexandra Keller, Daniela Berger, Georg Greiner, Bettina Wingelhofer

Cancers (Basel)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis